Cryptocurrencies
Analysts revise AbbVie stock price target ahead of earnings
Now what? For years, AbbVie’s (ABBV) blockbuster rheumatoid-arthritis treatment, Humira, which launched in 2002, was the world’s best-selling drug. Related: Analyst revises AbbVie stock price target on drug-sale estimates Sales eroded, however, as Humira faced competition Read more…